|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Crits-Christoph, P., Siqueland, L., Blaine, J.D., Frank, A., Luborsky, L., Onken, L.S., Muenz, L., Thase, M.E., Weiss, R.D., Gastfriend, D.R., Woody, G.E., Barber, J.P., Butler, S.F., Daley, D., Bishop, S., Najavits, L.M., Lis, J., Mercer, D., Griffin, M.L., Moras, K., Beck, A. (1997). The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry, 54(8), 721-726. DeLeon, G. (1984). The therapeutic community: Study of effectiveness. Rockville, MD: National Institute on Drug Abuse. Dole, V.P., and Nyswander, M.E. (1965). A medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association, 193, 646-650. Fischer, B., Rehm, J., Uchtenhagen, A., and Kirst, M. (2002). Compulsory treatment—what do we know and where should we go? European Addiction Research, 8(2), 52-53. Galanter, M., Keller, D.S., Dermatis, H., and Egelko, S. (2000). The impact of managed care on substance abuse treatment: A report of the American Society of Addiction Medicine. Journal of Addictive Diseases, 19(3), 13-34. Greenstein, R.A., O’Brien, C.P., Woody, G., Long, M., Coyle, G., Grabowski, J., and Vittor, A. (1981). Naltrexone: A short-term treatment alternative for opiate dependence. American Journal of Drug and Alcohol Abuse, 8(3), 291-300. Hall, S.M., Humfleet, G.L., Rues, V.I., Munoz, R.F., Hartz, D.T., and Maude-Griffin, R. (2002). Psychological intervention and antidepressant treatment in smoking cessation. Archives of General Psychiatry, 59(10), 930-936. Hays, J.T., Wolter, T.D., Eberman, K.M., Croghan, I.T., Offord, K.P, and Hurt, R.D. (2001). Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clinic Proceedings, 76(2), 124-133. Hubbard, R.L., Craddock, S.G., Flynn, P.M., Anderson, J., and Etheridge, R.M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 261-278. Hurt, R.D., Sachs, D.P.L., Glover, E.D., Offord, K.P., Johnston, J.A., Dale, L.C., Khayralla, M.A., Schroeder, D.R., Glover, P.N., Sullivan, R., Croughan, I.T., and Sullivan, P.M. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337(17), 1195-1202. Hurt, R.D., Ebbert, J.O., Hays, J.T., and Dale, L.C. (2003). Pharmacologic interventions for tobacco dependence. In A.W. Graham (Ed.), Principles of addiction medicine, 3rd ed. Chevy Chase, MD: American Society of Addiction Medicine. Inciardi, J.A., Martin, S.S., and Butzin, C.A. (in press). Five-year outcomes of therapeutic community treatment of drug-involved offenders after release from prison. Crime and Delinquency. Johnson, B.A., Ait-Daoud, N., Bowden, C.L., DiClemente, C.C., Roache, J.D., Lawson, K., Javors, M.A., and Ma, J.Z. (2003). Oral topiramate for treatment of alcohol dependence: A randomized controlled trial. Lancet, 361(9370), 1677-1685. Khantzian, E.J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259-1264. Kosten, T.R., and O’Connor, P.G. (2003.) Management of drug and alcohol withdrawal. New England Journal of Medicine, 348(18), 1786-1795. Krystal, J.H., Cramer, J.A., Krol, W.F., Kirk, G.F., and Rosenheck, R.A. (2001). Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine, 345(24), 1734-1739. Leshner, A.I. (1997). Addiction is a brain disease, and it matters. Science, 278(5335), 45-47. Leshner, A.I. (1999). Science-based views of drug addiction and its treatment. Journal of the American Medical Association, 282(14), 1314-1316.
|
|
|||||||||||||||
